Abstract
Our goal is to identify common single-nucleotide polymorphisms (SNPs) (minor allele frequency > 1%) that add predictive accuracy above that gained by knowledge of easily measured clinical variables. We take an algorithmic approach to predict each phenotypic variable using a combination of phenotypic and genotypic predictors. We perform our procedure on the first simulated replicate and then validate against the others. Our procedure performs well when predicting Q1 but is less successful for the other outcomes. We use resampling procedures where possible to guard against false positives and to improve generalizability. The approach is based on finding a consensus regarding important SNPs by applying random forests and the least absolute shrinkage and selection operator (LASSO) on multiple subsamples. Random forests are used first to discard unimportant predictors, narrowing our focus to roughly 100 important SNPs. A cross-validation LASSO is then used to further select variables. We combine these procedures to guarantee that cross-validation can be used to choose a shrinkage parameter for the LASSO. If the clinical variables were unavailable, this prefiltering step would be essential. We perform the SNP-based analyses simultaneously rather than one at a time to estimate SNP effects in the presence of other causal variants. We analyzed the first simulated replicate of Genetic Analysis Workshop 17 without knowledge of the true model. Post-conference knowledge of the simulation parameters allowed us to investigate the limitations of our approach. We found that many of the false positives we identified were substantially correlated with genuine causal SNPs.
Highlights
Our goal is to identify single-nucleotide polymorphisms (SNPs) that add predictive information for the phenotypic outcomes above that given by just the other phenotypes
We found that SNPs added predictive information only when Q1 was used as the outcome
Many of the effect sizes seen in the true simulated model were so small as to be often overshadowed by spurious associations
Summary
Our goal is to identify single-nucleotide polymorphisms (SNPs) that add predictive information for the phenotypic outcomes above that given by just the other phenotypes. This aim is motivated by the use of genetic testing in a clinical setting, where SNP genotypes can be used to identify a patient’s risk level better than measured clinical variables alone [1]. Our approach combines several well-known statistical procedures: stability selection, random forests, the least absolute shrinkage and selection operator (LASSO), and logistic regression. The. The LASSO procedure is a well-regarded approach to variable shrinkage and selection [3,7,8].
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have